Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients

Journal of Thoracic Oncology

Volumn 8, Issue 6, 2013, Pages 766-772

  Liam, Chong Kin ^a   Wahid, Mohamed Ibrahim A ^b   Rajadurai, Pathmanathan ^c   Cheah, Yoke Kqueen ^d   Ng, Tiffany Shi Yeen ^d  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Beacon International Specialist Centre   (Malaysia)

^c MONASH UNIVERSITY MALAYSIA   (Malaysia)

^d UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

EGFR mutations; Lung adenocarcinoma; Malaysian

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CHINESE; FEMALE; GENE MUTATION; HEREDITY; HUMAN; HUMAN TISSUE; INDIAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SMOKING CESSATION; TUMOR BIOPSY;

EID: 84879501751     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31828b5228     Document Type: Article

References (41)

1. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346. (Pubitemid 40425952)
2. Jackman DM, Yeap BY, Sequist LV, et al. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res 2006;12:3908-3914. (Pubitemid 44078074)
3. Liu F, Jiang B, Gong SJ, et al. [Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007;24:31-34.
4. Wang Y, Liu H, Chen J. [The predictive value of EGFR status in nonsmall cell lung cancer patients treated with EGFR-TKIs]. Zhongguo Fei Ai Za Zhi 2010;13:375-379.
5. Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 2003;8:303-306. (Pubitemid 36929716)
6. National Cancer Registry. Malaysian Cancer Statistics - Data and Figures. Peninsular Malaysia, 2006.
7. Liam CK, Pang YK, Leow CH, Poosparajah S, Menon A. Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country: experience of a university teaching hospital. Lung Cancer 2006;53:23-30. (Pubitemid 43831361)
8. National Cancer Registry. Third Report of the National Cancer Registry. Cancer incidence in Malaysia, 2003-2005. Kuala Lumpur, 2008.
9. Liam CK, Lim KH, Wong CM. Lung cancer in patients younger than 40 years in a multiracial Asian country. Respirology 2000;5:355-361. (Pubitemid 32049498)
10. Department of Statistics, Malaysia. Population Distribution and Basic Demographic Characteristics: Population and Housing Census of Malaysia 2010. Available at: http://www.statistics.gov.my/portal/download- Population/files/ census2010/Taburan-Penduduk-dan-Ciri-ciri- Asas-Demografi.pdf. Accessed June 7, 2012.
11. Rosell R, Moran T, Queralt C, et al.; Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958-967.
12. Tsao AS, Tang XM, Sabloff B, et al. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer. J Thorac Oncol 2006;1:231-239. (Pubitemid 47181440)
13. Mao C, Qiu LX, Liao RY, et al. KRAS mutations and resistance to EGFRTKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies. Lung Cancer 2010;69:272-278.
14. Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 2003;290:2149-2158. (Pubitemid 37432975)
15. Huang YS, Yang JJ, Zhang XC, et al. Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer. Chin Med J 2011;124:2457-2460.
16. Liu H, Li Y, Chen G, et al. [Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Nonsmall Cell Lung Cancer.]. Zhongguo Fei Ai Za Zhi 2009;12:1219-1228.
17. Qin BM, Chen X, Zhu JD, Pei DQ. Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy. Cell Res 2005;15:212-217. (Pubitemid 41653946)
18. Song GH, Di LJ, Ren J, et al. Analysis of EGFR mutation in Chinese non-small cell lung cancer patients. Journal of Modern Oncology 2008; 16:553-556.
19. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923. (Pubitemid 39665498)
20. Uramoto H, So T, Nagata Y, et al. Correlation between HLA alleles and EGFR mutation in Japanese patients with adenocarcinoma of the lung. J Thorac Oncol 2010;5:1136-1142.
21. Huang SF, Liu HP, Li LH, et al. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 2004;10:8195-8203.
22. Sahoo R, Harini VV, Babu VC, et al. Screening for EGFR mutations in lung cancer, a report from India. Lung Cancer 2011;73:316-319.
23. Toh CK, Ahmad B, Soong R, et al. Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas. J Thorac Oncol 2010;5: 17-22.
24. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139. (Pubitemid 38637993)
25. Paez JG, Jänne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-1500. (Pubitemid 38720929)
26. Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007;7:169-181.
27. Lund-Iversen M, Kleinberg L, Fjellbirkeland L, Helland A, Brustugun OT. Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations. J Thorac Oncol 2012;7:1471-1473.
28. Cote ML, Haddad R, Edwards DJ, et al. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol 2011;6:627-630.
29. Yang CH. EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 2008;60 Suppl 2:S23-S30.
30. Arrieta O, Cardona AF, Federico Bramuglia G, et al.; CLICaP. Genotyping non-small cell lung cancer (NSCLC) in Latin America. J Thorac Oncol 2011;6:1955-1959.
31. Ayub Q, Tyler-Smith C. Genetic variation in South Asia: assessing the influences of geography, language and ethnicity for understanding history and disease risk. Brief Funct Genomic Proteomic 2009;8:395-404.
32. Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat Genet 2004;36(11 Suppl):S28-S33.
33. Liam CK, Ruthranesan M, Lee CH, Pang YK, Chua KT, Lim BK. Outcomes of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor mutation status treated with gefitinib. Asia Pac J Clin Oncol 2012;8:267-274.
34. Suzuki H, Takahashi T, Kuroishi T, et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-736.
35. Ahrendt SA, Decker PA, Alawi EA, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 2001;92:1525-1530. (Pubitemid 32947838)
36. Mitsudomi T, Oyama T, Nishida K, et al. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin Cancer Res 1996;2:1185-1189. (Pubitemid 26238450)
37. Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001;61:2799-2803.
38. Ko YC, Cheng LS, Lee CH, et al. Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol 2000;151:140-147. (Pubitemid 30463644)
39. Salto-Tellez M, Tsao MS, Shih JY, et al. Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach. J Thorac Oncol 2011;6:1663-1669.
40. de Lima Lopes G Jr, Segel JE, Tan DS, Do YK, Mok T, Finkelstein EA. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer 2012;118:1032-1039.
41. Sun PL, Seol H, Lee HJ, et al. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. J Thorac Oncol 2012;7:323-330.